Regeneron Pharmaceuticals
REGN
#288
Rank
โ‚ฌ65.39 B
Marketcap
617,00ย โ‚ฌ
Share price
-0.61%
Change (1 day)
-15.85%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ34.50 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's total assets are โ‚ฌ34.50 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Regeneron Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ36.28 B21.26%
2023-12-31โ‚ฌ29.92 B9.87%
2022-12-31โ‚ฌ27.23 B21.27%
2021-12-31โ‚ฌ22.45 B60.95%
2020-12-31โ‚ฌ13.95 B5.58%
2019-12-31โ‚ฌ13.21 B28.84%
2018-12-31โ‚ฌ10.25 B40.43%
2017-12-31โ‚ฌ7.30 B10.18%
2016-12-31โ‚ฌ6.62 B29.23%
2015-12-31โ‚ฌ5.12 B62.58%
2014-12-31โ‚ฌ3.15 B47.67%
2013-12-31โ‚ฌ2.13 B35.86%
2012-12-31โ‚ฌ1.57 B54.32%
2011-12-31โ‚ฌ1.01 B24.44%
2010-12-31โ‚ฌ0.81 B58.32%
2009-12-31โ‚ฌ0.51 B-0.13%
2008-12-31โ‚ฌ0.51 B-19.21%
2007-12-31โ‚ฌ0.64 B44.61%
2006-12-31โ‚ฌ0.44 B24.03%
2005-12-31โ‚ฌ0.35 B2.5%
2004-12-31โ‚ฌ0.34 B-8.44%
2003-12-31โ‚ฌ0.38 B1.69%
2002-12-31โ‚ฌ0.37 B-33.22%
2001-12-31โ‚ฌ0.56 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Amgen
AMGN
โ‚ฌ77.42 B 124.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ4.16 B-87.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ25.08 B-27.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ165.60 B 380.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ92.15 B 167.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ130.83 B 279.20%๐Ÿ‡ซ๐Ÿ‡ท France